Jenna Styan joins RaySearch as Director of Corporate Strategy
RaySearch Laboratories AB (publ) appoints Jenna Styan from Siemens Healthineers (Varian) as Director of its new Corporate Development & Strategy department to drive growth and strengthen the company’s strategic capabilities.
Jenna Styan brings extensive experience from the global oncology software and treatment planning industry. She has held several strategic leadership positions at Varian and Siemens Healthineers (Varian), including roles leading software sales, product sales specialists, treatment planning system (TPS) sales, and clinical solutions across EMEA, most recently serving as VP, Head of EMEA Cancer Therapy Imaging.
Her background also includes hands-on clinical experience as a dosimetrist, along with academic degrees in Clinical Technology (Radiotherapy) and Business Management & Languages, enabling her to bridge clinical needs, product strategy, and commercial development effectively.
“I’m truly excited to join the team and contribute with the knowledge and experience I’ve gained at Varian. I´m looking forward to learning, collaborating, and making a real impact together”, says Jenna Styan.
“Jenna’s expertise and leadership will be key to establishing this new department. We will grow the team to strengthen our strategic capabilities and drive RaySearch’s future growth,” comments Johan Löf, founder and CEO of RaySearch.
Jenna will assume her role as Director of Corporate Development & Strategy on April 1, 2026, and will be a member of the group management team.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Tel: +46 (0) 8 510 530 00
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.